Compound ID | 321
Synonym(s): CS-023 | RO4908463 | R-115685
Class: Beta-lactam (carbapenem)
| Spectrum of activity: | Gram-positive & Gram-negative | 
| Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets. Carbapenems have a very broad spectrum incl. non-fermenters and are not hydrolysed by most beta-lactamases with exception of carbapenemases. | 
| Institute where first reported: | Daiichi Sankyo Pharmaceutical; Hoffman-La Roche, Switzerland | 
| Year first mentioned: | 2000 | 
| Highest developmental phase: | Phase 2 | 
| Development status: | Inactive | 
| Reason Dropped: | Discontinued for unknown reasons (LS) | 
| Chemical structure(s): | |||||||||||
| 
 | 
 | 
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9809656 | 
| Guide to Pharmacology: | tomopenem | 
| Citations: |  |